Elsevier Publishes First Books in Cell Press Reviews Series

New book series brings Cell Press journal content on cell biology, cancer therapeutics and stem cells to researchers without institutional access

Waltham, MA, December 10, 2013

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of the first titles in the new Cell Press Reviews book series, making review content from Cell Press journals more accessible to researchers without institutional access and to others interested in learning more about the topics at a high level. The first book to publish, Cell Press Reviews: Core Concepts in Cell Biology, will be presented at the upcoming American Society for Cell Biology annual meeting in New Orleans, LA, December 14–18, Booth #224.

"We are delighted to present these high-impact, comprehensive reviews in book format for the first time," said Emilie Marcus, CEO of Cell Press and Editor of Cell. "Our editorial team carefully selected review articles that not only provide an overview of recent advances in these fields, but also look to what is coming next in these areas."

Cell Press's in-house journal editors, who are subject-matter experts, curated the high-quality, high-impact journal review articles into accessible books on the current state and future direction of cell biology, cancer therapeutics and stem cells to model and treat disease.

"Nothing beats a book of high-quality review articles to provide a researcher with timely, comprehensive coverage of a topic," said Suzanne BeDell, Managing Director, Science and Technology Books at Elsevier. "Working together with Cell Press to make its definitive reviews available in book form supports our ongoing goal to offer high-quality content that makes researchers, students, educators and practitioners more productive."

The books in the series, published under the AP Cell imprint, include:

The books are available on the Elsevier Store and through other online book retailers.

# # #

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Michelle McMahon
Publicity Manager, Science & Technology Books
Elsevier
+1 781 663 2268
m.mcmahon.1@elsevier.com